55th Annual Meeting of the American Society of Hematology

Eadie, L. (Participant)

Activity: Other


White DL, Saunders VA, Eadie LN, Yeung, D, Hughes TP.
The depth of in vivo kinase inhibition achieved over the first month of nilotinib therapy predicts for subsequent molecular response and is closely related to nilotinib plasma levels.
Oral Presentation
New Orleans, Louisiana
Period7 Dec 201310 Dec 2013